研究论文开放获取
Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors
Ivone Gomes, Achla Gupta, Elyssa B. Margolis, Lloyd D. Fricker, Lakshmi A. Devi
Neurosciences Institute Icahn School of Medicine at Mount Sinai University of California, San Francisco Albert Einstein College of Medicine
来源Molecular Pharmacology
年份2024
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
1260
24
1225
26
关键指标
24
被引次数 · OpenAlex
7.22
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 2%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
89
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Treatment of Major Depression
Neuroscience and Neuropharmacology Research · Receptor Mechanisms and Signaling
参考文献 89
What has serotonin to do with depression?
被引 380Philip J. Cowen, Michael Browning · World Psychiatry · 2015
Thr353, Located within the COOH-terminal Tail of the ´ Opiate Receptor, Is Involved in Receptor Down-regulation
被引 108Svetlana Cvejic, Nino Trapaidze, Curt Cyr · Journal of Biological Chemistry · 1996
Potentiation of μ‐opioid receptor‐mediated signaling by ketamine
被引 134Achla Gupta, Lakshmi A. Devi, Ivone Gomes · Journal of Neurochemistry · 2011
此处列出前 3 条
引用本文 24
Effect of naltrexone pretreatment on ketamine-induced glutamatergic activity and symptoms of depression: a randomized crossover study
被引 37Luke A. Jelen, David J. Lythgoe, James Stone · Nature Medicine · 2025
Beyond NMDA Receptors: A Narrative Review of Ketamine’s Rapid and Multifaceted Mechanisms in Depression Treatment
被引 18Z Antoś, Xawery Żukow, Laura Bursztynowicz · International Journal of Molecular Sciences · 2024
Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review
被引 13Mary R. Shen, D Campbell, Anika Kopczynski · Frontiers in Psychiatry · 2025
按被引量排序，此处列出前 3 条